No Data
No Data
BioAtla Announces Upcoming Poster Presentation at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting
BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
BTIG Initiates BioAtla(BCAB.US) With Buy Rating, Announces Target Price $13
BTIG analyst Justin Zelin initiates coverage on $BioAtla(BCAB.US)$ with a buy rating, and sets the target price at $13.According to TipRanks data, the analyst has a success rate of 41.5% and a total
Buy Rating for BioAtla: Promising Pipeline and Strategic Partnerships Fuel Optimistic Outlook
'Big Short' Fame Michael Burry Bets Big On China, Reveals Alibaba As Top Holding — JD.com And Baidu Also Feature On Scion's Portfolio
The stock holdings of subprime 'The Big Short' unexpectedly halved in the second quarter, with an increased shareholding in Alibaba becoming the top weighted stock.
Michael Burry, who once made Wall Street tremble, what has he sniffed out this time? His investment company Scion reported that it has increased its shareholding in Alibaba by 0.03 million shares in the second quarter, with its holding value increasing from 9 million US dollars in the first quarter to 11.2 million US dollars. Scion also increased its shareholding in Baidu by more than 0.03 million shares in the second quarter, with a shareholding value of 6.5 million US dollars at the end of June. The company reduced its holdings in US stocks dramatically in the second quarter after clearing out popular US stocks in the first quarter.